Worldwide Peptide Therapeutics Industry to 2030 – Featuring Apellis Pharmaceuticals, Eli Lilly and Novo Nordisk Among Others

NEXT STORY
Global Emission Monitoring Systems Market (2021 to 2026) – Growth, Trends, COVID-19 Impact and Forecasts
PREV STORY
FDA Approves Updated ADUHELM™ Prescribing Information to Emphasize Population Studied in Clinical Trials
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

HUTCHMED Initiates SURTORI-01, a Phase III Trial of SULANDA® in Combination with TUOYI® in the Treatment of Advanced Neuroendocrine Carcinoma in China

author_avatar
NASDAQ Market News

BioAegis Therapeutics Enrolls First Patients in Phase 1b/2a Community-Acquired Pneumonia Study and Raises $4 MM in Equity Round

MORRISTOWN, N.J., Sept. 18, 2018 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc. announced that it ...

author_avatar
NASDAQ Market News

Trevena Announces Advancement of TRV045 Into Clinical Development for Diabetic Neuropathic Pain

author_avatar
NASDAQ Market News